Clinical Trial Update: A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

The document describes a Phase 1 clinical trial of aumolertinib in European participants with non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aumolertinib (Aumolertinib)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING